CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-03 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −55,000 | $55.33 | $3.0M | 108,760 |
| 2024-06-03 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −13,750 | 0 | ||
| 2024-06-03 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −41,250 | 0 | ||
| 2024-05-30 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion 10b5-1 | +21,195 | $23.75 | $503K | 127,329 |
| 2024-05-30 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −21,195 | $55.00 | $1.2M | 106,134 |
| 2024-05-30 | Flammer Martina M.D. Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −21,195 | 35,325 | ||
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +76,731 | $28.88 | $2.2M | 197,666 |
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +27,074 | $24.70 | $669K | 228,194 |
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +25,046 | $34.03 | $852K | 256,694 |
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +39,446 | $26.46 | $1.0M | 299,594 |
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +20,111 | $26.43 | $532K | 323,159 |
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion 10b5-1 | +32,156 | $17.07 | $549K | 358,769 |
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −220,564 | $50.00 | $11.0M | 117,481 |
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −76,731 | 11,455 | ||
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −27,074 | 4,362 | ||
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −25,046 | 17,100 | ||
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −39,446 | 25,740 | ||
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −20,111 | 39,275 | ||
| 2024-05-29 | Bonstein Sara Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −32,156 | 59,350 | ||
| 2024-05-28 | Wise John Drayton Chief Commercial Officer | Sale 10b5-1 | −1,602 | $48.95 | $78K | 121,657 |
Page 38 of 42 · 826 trades